Pieter A. de Graeff
-
- Heart Failure Treatment and Management 13
- Blood Pressure and Hypertension Studies 12
- Cardiovascular Function and Risk Factors 7
- Cardiac electrophysiology and arrhythmias 6
- Toxicology top 1%
- Nephrology top 2%
- Geriatrics and Gerontology top 2%
-
- Health Systems, Economic Evaluations, Quality of Life 12
- Pharmaceutical Economics and Policy 8
-
- Pharmaceutical industry and healthcare 6
-
- Pharmaceutical studies and practices 6
Pieter A. de Graeff
61 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 109
- Cardiology and Cardiovascular Medicine 1.3k
- Toxicology 140
- Nephrology 278
- Geriatrics and Gerontology 125
- Endocrinology, Diabetes and Metabolism 350
Countries citing papers authored by Pieter A. de Graeff
This map shows the geographic impact of Pieter A. de Graeff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter A. de Graeff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter A. de Graeff more than expected).
Fields of papers citing papers by Pieter A. de Graeff
This network shows the impact of papers produced by Pieter A. de Graeff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter A. de Graeff. The network helps show where Pieter A. de Graeff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pieter A. de Graeff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 17 | |
| 2 | 2012 | 77 | |
| 3 | 2011 | 243 | |
| 4 | 2011 | 4 | |
| 5 | 2010 | 45 | |
| 6 | 2006 | 23 | |
| 7 | 2005 | 20 | |
| 8 | 2005 | 18 | |
| 9 | 2004 | 75 | |
| 10 | 2003 | 13 | |
| 11 | 2001 | 13 | |
| 12 | 2000 | 21 | |
| 13 | 1997 | 43 | |
| 14 | 1997 | 19 | |
| 15 | 1996 | 37 | |
| 16 | 1995 | 7 | |
| 17 | 1993 | 9 | |
| 18 | 1992 | 2 | |
| 19 | 1991 | 5 | |
| 20 | 1990 | 2 |
About Pieter A. de Graeff
Pieter A. de Graeff is a scholar working on Toxicology, Cardiology and Cardiovascular Medicine and Family Practice, having authored 63 papers that have together received 2.1k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (13 papers), Blood Pressure and Hypertension Studies (12 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers), Pharmaceutical Economics and Policy (8 papers), Cardiovascular Function and Risk Factors (7 papers), Pharmaceutical industry and healthcare (6 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Pharmaceutical studies and practices (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.3k citations), Toxicology (140 citations) and Nephrology (278 citations). Pieter A. de Graeff has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Dirk J. van Veldhuisen, Sabine M. J. M. Straus, Dick de Zeeuw, Flora M. Haaijer‐Ruskamp, Hans Hillege, Wiek H. van Gilst, Frank A. Holtkamp, Hiddo J.L. Heerspink, Peter G. M. Mol and Kong I. Lie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.